U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.1155del (p.Leu386fs) AND not provided

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Nov 3, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000598690.6

Allele description [Variation Report for NM_000162.5(GCK):c.1155del (p.Leu386fs)]

NM_000162.5(GCK):c.1155del (p.Leu386fs)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.1155del (p.Leu386fs)
HGVS:
  • NC_000007.14:g.44145598del
  • NG_008847.2:g.57576del
  • NM_000162.5:c.1155delMANE SELECT
  • NM_001354800.1:c.1155del
  • NM_001354801.1:c.144del
  • NM_001354802.1:c.15del
  • NM_001354803.2:c.189del
  • NM_033507.3:c.1158del
  • NM_033508.3:c.1152del
  • NP_000153.1:p.Leu386fs
  • NP_001341729.1:p.Leu386fs
  • NP_001341730.1:p.Leu49fs
  • NP_001341731.1:p.Leu6fs
  • NP_001341732.1:p.Leu64fs
  • NP_277042.1:p.Leu387fs
  • NP_277043.1:p.Leu385fs
  • LRG_1074t1:c.1155del
  • LRG_1074t2:c.1158del
  • LRG_1074:g.57576del
  • LRG_1074p1:p.Leu386fs
  • LRG_1074p2:p.Leu387fs
  • NC_000007.13:g.44185194del
  • NC_000007.13:g.44185197del
  • NM_000162.3:c.1155del
  • NM_000162.3:c.1155delG
Protein change:
L385fs
Links:
dbSNP: rs1400535021
NCBI 1000 Genomes Browser:
rs1400535021
Molecular consequence:
  • NM_000162.5:c.1155del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354800.1:c.1155del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354801.1:c.144del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354802.1:c.15del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354803.2:c.189del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_033507.3:c.1158del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_033508.3:c.1152del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000709947GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Likely pathogenic
(May 11, 2020)
germlineclinical testing

Citation Link,

SCV004295137Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 3, 2023)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis.

Grupe A, Hultgren B, Ryan A, Ma YH, Bauer M, Stewart TA.

Cell. 1995 Oct 6;83(1):69-78.

PubMed [citation]
PMID:
7553875

Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.

Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, Shelton KD, Lindner J, Cherrington AD, Magnuson MA.

J Biol Chem. 1999 Jan 1;274(1):305-15.

PubMed [citation]
PMID:
9867845
See all PubMed Citations (8)

Details of each submission

From GeneDx, SCV000709947.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Frameshift variant predicted to result in protein truncation, as the last 80 amino acids are replaced with 15 different amino acids, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (Stenson et al., 2014); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 23771925)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV004295137.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

This sequence change creates a premature translational stop signal (p.Leu386Trpfs*16) in the GCK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GCK are known to be pathogenic (PMID: 7553875, 9867845, 14578306, 24323243, 25015100). This variant is present in population databases (no rsID available, gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of maturity onset diabetes of the young (PMID: 23771925, 32533152). ClinVar contains an entry for this variant (Variation ID: 503699). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 29, 2024